Publication:
Determination of CYP2C19 Polymorphism, Side Effects, and Medication Adherence in Patients Who have Utilized Selective Serotonin Reuptake Inhibitors

No Thumbnail Available

Date

2016-06-01T00:00:00Z

Authors

Deniz, Semanur
SANCAR, MESUT
OKUYAN, BETÜL
ATA, PINAR
Ozakpinar, Ozlem Bingol
TALAS, Anil
GUNES, Tufan
CALISKAN, Mecit
Izzettin, Fikret Vehbi

Journal Title

Journal ISSN

Volume Title

Publisher

Research Projects

Organizational Units

Journal Issue

Metrics

Search on Google Scholar

Abstract

Objective: The aim of this study is to determine relationship of cytochrome P-450 2C19 (CYP2C19) enzymes polymorphism, side effects, and medication adherence in patients who have been diagnosed with major depression and have utilized selective serotonin reuptake inhibitors.

Description

Keywords

Citation

Deniz S., SANCAR M., OKUYAN B., ATA P., Ozakpinar O. B. , TALAS A., GUNES T., CALISKAN M., Izzettin F. V. , -Determination of CYP2C19 Polymorphism, Side Effects, and Medication Adherence in Patients Who have Utilized Selective Serotonin Reuptake Inhibitors-, KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.26, ss.152-160, 2016
Page Views

0

File Downloads

0

Sustainable Development Goals